Alkermes PLC (ALKS)
23.40
+0.19
(+0.82%)
USD |
NASDAQ |
May 31, 16:00
23.39
-0.01
(-0.04%)
After-Hours: 20:00
Alkermes Enterprise Value: 3.505B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 3.505B |
| May 30, 2024 | 3.473B |
| May 29, 2024 | 3.486B |
| May 28, 2024 | 3.564B |
| May 24, 2024 | 3.610B |
| May 23, 2024 | 3.606B |
| May 22, 2024 | 3.642B |
| May 21, 2024 | 3.664B |
| May 20, 2024 | 3.671B |
| May 17, 2024 | 3.632B |
| May 16, 2024 | 3.684B |
| May 15, 2024 | 3.630B |
| May 14, 2024 | 3.689B |
| May 13, 2024 | 3.727B |
| May 10, 2024 | 3.615B |
| May 09, 2024 | 3.650B |
| May 08, 2024 | 3.623B |
| May 07, 2024 | 3.706B |
| May 06, 2024 | 3.623B |
| May 03, 2024 | 3.615B |
| May 02, 2024 | 3.583B |
| May 01, 2024 | 3.608B |
| April 30, 2024 | 3.698B |
| April 29, 2024 | 3.755B |
| April 26, 2024 | 3.721B |
| Date | Value |
|---|---|
| April 25, 2024 | 3.680B |
| April 24, 2024 | 3.715B |
| April 23, 2024 | 3.649B |
| April 22, 2024 | 3.617B |
| April 19, 2024 | 3.580B |
| April 18, 2024 | 3.565B |
| April 17, 2024 | 3.607B |
| April 16, 2024 | 3.567B |
| April 15, 2024 | 3.609B |
| April 12, 2024 | 3.677B |
| April 11, 2024 | 3.773B |
| April 10, 2024 | 3.968B |
| April 09, 2024 | 4.067B |
| April 08, 2024 | 3.932B |
| April 05, 2024 | 3.964B |
| April 04, 2024 | 3.912B |
| April 03, 2024 | 4.000B |
| April 02, 2024 | 4.074B |
| April 01, 2024 | 4.154B |
| March 31, 2024 | 4.125B |
| March 28, 2024 | 4.097B |
| March 27, 2024 | 4.128B |
| March 26, 2024 | 4.048B |
| March 25, 2024 | 4.138B |
| March 22, 2024 | 4.134B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.812B
Minimum
Mar 18 2020
5.279B
Maximum
Jun 22 2023
3.564B
Average
3.591B
Median
Enterprise Value Benchmarks
| Endo International PLC (DELISTED) | -777.78M |
| Jazz Pharmaceuticals PLC | 10.53B |
| Medtronic PLC | 123.93B |
| Perrigo Co PLC | 7.167B |
| Iterum Therapeutics PLC | 26.71M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 36.83M |
| Revenue (Quarterly) | 350.37M |
| Total Expenses (Quarterly) | 307.06M |
| EPS Diluted (Quarterly) | 0.21 |
| Gross Profit Margin (Quarterly) | 83.26% |
| Profit Margin (Quarterly) | 10.51% |
| Earnings Yield | 10.81% |
| Operating Earnings Yield | 12.63% |
| Normalized Earnings Yield | 12.09 |